Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Non-Current Liabilities ₹12 Cr₹10.00 Cr₹8.66 Cr₹7.76 Cr₹7.73 Cr

What is the latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹12 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹12 Cr
Mar2024₹10.00 Cr
Mar2023₹8.66 Cr
Mar2022₹7.76 Cr
Mar2017₹7.73 Cr

How is Total Non-Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹12 Cr
18.16
Mar2024 ₹10.00 Cr
15.49
Mar2023 ₹8.66 Cr
11.53
Mar2022 ₹7.76 Cr
0.36
Mar2017 ₹7.73 Cr -

Compare Total Non-Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,231.4 Cr -3.3% -6.1% -30.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.3%

-6.1%

-30.1%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses